Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
25 hedge funds and large institutions have $3.91M invested in Acer Therapeutics Inc in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
13% less capital invested
Capital invested by funds: $4.47M → $3.91M (-$562K)
17% less funds holding
Funds holding: 30 → 25 (-5)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
88% less call options, than puts
Call options by funds: $5K | Put options by funds: $41K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$93.1K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.38K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.59K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$508 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$69K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$52.2K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$42K |
| 4 |
Millennium Management
New York
|
-$33K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| – | -$3K | -1,000 | Closed |
|
27
Morgan Stanley
New York
| – | +$3 | +1 | New |
|
28
Wells Fargo
San Francisco,
California
| – | +$36 | +14 | +32% |
|
ACER Hedge Fund Activity: Q3 2021 in Review
25 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2021, worth a combined $3.91M — down 13% from $4.47M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ACER and 2 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $93.1K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $69K sold.
- 25 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2021, down from 30 in Q2 2021.
- Funds reported $3.91M of Acer Therapeutics Inc stock for Q3 2021, down 13% quarter-over-quarter.
- 2 funds opened new Acer Therapeutics Inc positions in Q3 2021 and 7 closed out, a net change of -5 holders.
- The largest Acer Therapeutics Inc buyer in Q3 2021 was Citadel Advisors, an estimated $93.1K added.
- The largest Acer Therapeutics Inc seller in Q3 2021 was Two Sigma Advisers, an estimated $69K sold.
Based on aggregated 13F filings for Q3 2021.